Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Current Treatment of Anterior Communicating Artery Aneurysms: Single Center Study

O. Navrátil, K. Ďuriš, V. Juráň, K. Svoboda, J. Hustý, E. Hovorka, E. Neuman, A. Mrlian, M. Smrčka,

. 2020 ; 10 (8) : . [pub] 20200731

Language English Country Switzerland

Document type Journal Article

INTRODUCTION: Anterior communicating artery aneurysms (ACoAAs) are the most frequent intracranial aneurysms treated at neurosurgical departments with a vascular program. MATERIAL AND METHODS: We reviewed patients with ACoAAs in a single institution over ten years (2008-2017). The focus was on the final outcome; complications, age, and clinical condition with respect to modalities were analyzed. RESULTS: A total of 198 patients treated during this period was included in the study: 176 patients had a ruptured ACoAA and 22 had an unruptured ACoAA. Then, 127 (71%) were treated surgically and 51 (29%) by endovascular means. Out of the whole series, a good recovery occurred in 123 patients (62%), moderate disability in 11 (5.5%), severe disability in 19 (10%), vegetative state in 11 (5.5%), and death in 34 (17%). In the 157 patients (72.5%) with a subarachnoid hemorrhage (SAH), both modalities had a favorable outcome: 27.5% had an unfavorable outcome, 12% had complications in surgery versus 17.6% during endovascular treatment. No statistical difference in outcome, complications, and age was noted between modalities. Surgical treatment was more frequently adopted for patients in a better clinical condition (p ≤ 0.05). CONCLUSION: More than two thirds of the patients (72.5%) reached a favorable outcome. There was no difference in age between the treatment modalities. Risks of complications are present and specific for both modalities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20021896
003      
CZ-PrNML
005      
20201204093214.0
007      
ta
008      
201125s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/brainsci10080501 $2 doi
035    __
$a (PubMed)32751951
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Navrátil, Ondřej $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
245    10
$a Current Treatment of Anterior Communicating Artery Aneurysms: Single Center Study / $c O. Navrátil, K. Ďuriš, V. Juráň, K. Svoboda, J. Hustý, E. Hovorka, E. Neuman, A. Mrlian, M. Smrčka,
520    9_
$a INTRODUCTION: Anterior communicating artery aneurysms (ACoAAs) are the most frequent intracranial aneurysms treated at neurosurgical departments with a vascular program. MATERIAL AND METHODS: We reviewed patients with ACoAAs in a single institution over ten years (2008-2017). The focus was on the final outcome; complications, age, and clinical condition with respect to modalities were analyzed. RESULTS: A total of 198 patients treated during this period was included in the study: 176 patients had a ruptured ACoAA and 22 had an unruptured ACoAA. Then, 127 (71%) were treated surgically and 51 (29%) by endovascular means. Out of the whole series, a good recovery occurred in 123 patients (62%), moderate disability in 11 (5.5%), severe disability in 19 (10%), vegetative state in 11 (5.5%), and death in 34 (17%). In the 157 patients (72.5%) with a subarachnoid hemorrhage (SAH), both modalities had a favorable outcome: 27.5% had an unfavorable outcome, 12% had complications in surgery versus 17.6% during endovascular treatment. No statistical difference in outcome, complications, and age was noted between modalities. Surgical treatment was more frequently adopted for patients in a better clinical condition (p ≤ 0.05). CONCLUSION: More than two thirds of the patients (72.5%) reached a favorable outcome. There was no difference in age between the treatment modalities. Risks of complications are present and specific for both modalities.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ďuriš, Kamil $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic. Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic.
700    1_
$a Juráň, Vilém $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
700    1_
$a Svoboda, Karel $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
700    1_
$a Hustý, Jakub $u Department of Radiology and Nuclear Medicine, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Radiology and Nuclear Medicine, University Hospital Brno, 62500 Brno, Czech Republic.
700    1_
$a Hovorka, Evžen $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
700    1_
$a Neuman, Eduard $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
700    1_
$a Mrlian, Andrej $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
700    1_
$a Smrčka, Martin $u Department of Neurosurgery, Faculty of Medicine, Masaryk University Brno, 62500 Brno, Czech Republic. Department of Neurosurgery, University Hospital Brno, 62500 Brno, Czech Republic.
773    0_
$w MED00198694 $t Brain sciences $x 2076-3425 $g Roč. 10, č. 8 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32751951 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201204093211 $b ABA008
999    __
$a ind $b bmc $g 1591605 $s 1112568
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 8 $e 20200731 $i 2076-3425 $m Brain sciences $n Brain Sci $x MED00198694
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...